International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting

Arianna J. Zhang, Gretchen Ball, Melissa Zundell, Rosario Agüero, Danielle Yee, Ali Shields, Christina Asare, Kristina Navrazhina, Winston Liu, Negar Foolad, Jeffery Kwock, Priyanka Tejwani, Hassan Hamade, Tarannum Jaleel, Daniel Butler, Nanette Silverberg, Leigh Nattkemper, Daniel M. Siegel, Jerry Tan, Brian S. KimCecilia Larocca, Michi M. Shinohara, Athena Ehlert, John Latella, Emma Guttman-Yassky, James G. Krueger, Vibeke Strand, April W. Armstrong, Joseph F. Merola, Lourdes Perez-Chada, Alice B. Gottlieb

Research output: Contribution to journalArticlepeer-review

Abstract

Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization whose mission is to improve the availability of evidence-based, consensus-driven outcome measures for dermatological diseases. IDEOM facilitates collaboration between stakeholders from various backgrounds, including researchers, patients, physicians, and industry representatives, to develop objective benchmark metrics that enable better treatment and management of dermatologic conditions. Summary: The 2023 IDEOM Annual Meeting was held June 23-24, 2023. Workgroups in psoriatic disease, hidradenitis suppurativa, geriatric dermatology, connective tissue disease, vitiligo, itch, actinic keratosis, acne, and cutaneous T-cell lymphoma discussed the progress of their respective outcome-measures research. This report summarizes each workgroup’s updates since the 2022 annual meeting and their next steps as established during the 2023 IDEOM Annual Meeting.

Original languageEnglish
Pages (from-to)1114-1120
Number of pages7
JournalJournal of Drugs in Dermatology
Volume23
Issue number12
DOIs
StatePublished - Dec 2024

Fingerprint

Dive into the research topics of 'International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting'. Together they form a unique fingerprint.

Cite this